breast cancer

HER2 levels may aid in treatment selection for metastatic breast...

admin — Mon, 01 Dec 2008 23:00:00 -0600

(American Association for Cancer Research) Findings published in the Dec. 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. In addition, a misclassification of metastatic breast cancer patients by as much as 10 percent prevents some people from receiving optimal therapy.

European ancestry increases breast cancer risk among Latinas

admin — Sun, 30 Nov 2008 23:00:00 -0600

(American Association for Cancer Research) Latina women have a lower risk of breast cancer than European or African-American women generally, but those with higher European ancestry could be at increased risk, according to data published in the Dec. 1 issue of Cancer Research, a journal of the American Association for Cancer Research.

Does Hormone Treatment Predispose Patients To Breast Cancer?

admin — Sat, 29 Nov 2008 19:00:06 -0600

Breast cancer, the leading cause of death among women in France, is the most commonly occurring cancer in women. Sporadic breast cancer, which is non-hereditary, turns out to be the most widespread, representing 85 to 90% of all cases, but remains the least well-known. Researchers have just discovered the cause of 50% of sporadic breast cancers.

Isolated Breast Cancer Cells In Sentinel Lymph Node Associated W...

admin — Fri, 21 Nov 2008 18:00:10 -0600

Women who are found to have isolated breast cancer cells upon sentinel lymph node biopsy have a risk of having metastases in other lymph nodes.

Calorie Restriction And Exercise Show Breast Cancer Prevention D...

admin — Fri, 21 Nov 2008 09:45:19 -0600

Scientists have identified pathways by which a reduced-calorie diet and exercise can modify a postmenopausal woman's risk of breast cancer.

Two new compounds show promise for eliminating breast cancer tum...

admin — Tue, 18 Nov 2008 23:00:00 -0600

(University of Central Florida) Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors. Researchers have observed no negative side effects so far.

Clue To Stopping Breast-cancer Metastasis Discovered

admin — Tue, 18 Nov 2008 11:00:03 -0600

If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research takes a step in that direction.

Breast cancer common among women with family history but without...

admin — Sun, 16 Nov 2008 23:00:00 -0600

(American Association for Cancer Research) New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation. This may facilitate earlier detection and prevention among high-risk women.

Vigorous Activity Protects Against Breast Cancer, Study Shows

admin — Mon, 03 Nov 2008 10:00:19 -0600

Normal-weight women who carry out lots of vigorous exercise are approximately 30 percent less likely to develop breast cancer than those who don't exercise vigorously. A study of more than 30,000 postmenopausal American women has revealed that a sedentary lifestyle can be a risk factor for the disease -- even in women who are not overweight.

Cancer Drug Resistance: 'New' Estrogen Receptor Found To Be Key ...

admin — Thu, 30 Oct 2008 11:15:08 -0500

Researchers have discovered a novel way in which breast cancer cells become resistant to tamoxifen, the world's largest-selling breast cancer prevention and treatment drug. They say the findings could provide a way to identify tamoxifen users who are no longer benefiting from the drug, allowing doctors to try another therapy option sooner.